NIKKEI 225
38,653.20 -293.73 (-0.75%) HANG SENG
19,267.97 +47.35 (+0.25%) CRUDE OIL
79.06 -0.20 (-0.25%) GOLD FUTURES
2,420.60 -5.30 (-0.22%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
54,876.26 -988.36 (-1.77%)
Aspira Women's Health Inc. (AWH)
After hours:
| Previous close | 2.5400 |
| Open | 2.5200 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 2.5000 - 2.7599 |
| 52-week range | 2.1700 - 6.7500 |
| Volume | |
| Avg. volume | 24,822 |
| Market cap | 33.738M |
| Beta (5Y monthly) | 1.57 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Aspira Women’s Health to Present at the A.G.P. Healthcare Showcase on May 21
AUSTIN, Texas, May 16, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that management will present a corporate overview at the Alliance Global Partner’s Healthcare Showcase taking place virtually on Tuesday, May 21, 2024. Presentation Details:Date:Tuesday, May 21, 2024Time:11:00 am ESTWebcast:Click HERE to register for t
- GlobeNewswire
Aspira Women’s Health Reports First Quarter 2024 Financial Results
Q1 2024 OvaSuiteSM revenue of $2.2 million and volume of 5,829 units Q1 2024 cash utilization of $4.4 million, a decrease of 22% compared to Q1 2023 Conference Call and Webcast scheduled for today at 8:30 am ET AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today reported its financial results for the first quarte
- GlobeNewswire
UPDATE -- Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that the Company will report its financial results for the three months ended March 31, 2024, on Wednesday, May 15, 2024. Management will also host a conference call at 8:30 a.m. Eastern Time to discuss financial results and provide a corporate update.
